BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26455545)

  • 1. Demyelination preceding a diagnosis of central nervous system lymphoma.
    Kalus S; Di Muzio B; Gaillard F
    J Clin Neurosci; 2016 Feb; 24():146-8. PubMed ID: 26455545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma.
    Ng S; Butzkueven H; Kalnins R; Rowe C
    J Clin Neurosci; 2007 Nov; 14(11):1126-9. PubMed ID: 17890092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.
    Husseini L; Saleh A; Reifenberger G; Hartung HP; Kieseier BC
    Can J Neurol Sci; 2012 Jan; 39(1):6-10. PubMed ID: 22384490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma?
    Qiu T; Chanchotisatien A; Qin Z; Wu J; Chu S
    World Neurosurg; 2021 Jan; 145():172-177. PubMed ID: 32949800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
    Kvarta MD; Sharma D; Castellani RJ; Morales RE; Reich SG; Kimball AS; Shin RK
    BMC Neurol; 2016 May; 16():72. PubMed ID: 27206499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes.
    Achi HE; Lally JE; Riascos RF; Zhu JJ; Tandon N; Esquenazi Y; Bhattacharjee MB; Ballester LY
    Ann Clin Lab Sci; 2018 Jul; 48(4):534-537. PubMed ID: 30143499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma in immunocompetent patients: a retrospective review of MRI features.
    Sutherland T; Yap K; Liew E; Tartaglia C; Pang M; Trost N
    J Med Imaging Radiat Oncol; 2012 Jun; 56(3):295-301. PubMed ID: 22697326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
    Ohe Y; Hayashi T; Mishima K; Nishikawa R; Sasaki A; Matsuda H; Uchino A; Tanahashi N
    Intern Med; 2013; 52(4):483-8. PubMed ID: 23411706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
    Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary CNS Lymphoma vs. Tumefactive Multiple Sclerosis: A Diagnostic Challenge.
    Naeem SB; Niazi F; Baig A; Sadiq H; Sattar M
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):66-68. PubMed ID: 29290197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation Preceding and Accompanying Primary Central Nervous System Lymphoma: Case Study and Literature Review.
    Lu JQ; O'Kelly C; Girgis S; Emery D; Power C; Blevins G
    World Neurosurg; 2016 Apr; 88():692.e1-692.e8. PubMed ID: 26724610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
    Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
    Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
    Yiu EM; Laughlin S; Verhey LH; Banwell BL;
    J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma.
    Bajagain M; Oyoshi T; Hanada T; Higa N; Hiraki T; Kamimura K; Kuroki S; Yoshimoto K
    Surg Neurol Int; 2020; 11():342. PubMed ID: 33194276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumefactive demyelinating lesion: experience with two unusual patients.
    Sinha MK; Garg RK; Bhatt ML; Chandra A
    J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
    XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
    Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Brain Lesions as Omen of Primary Central Nervous System Lymphoma: A Case Report and Literature Review.
    Kim YJ; Kim SK; Jung TY; Kim IY; Lee KH; Moon KS
    Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33557224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumefactive Demyelination versus Primary Central Nervous System Lymphoma on
    Biswas S; Nagaraj C; Mangalore S; Gupta AK
    Indian J Nucl Med; 2019; 34(3):237-240. PubMed ID: 31293309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.